210 related articles for article (PubMed ID: 15914049)
1. Validation of the PAC-SYM questionnaire for opioid-induced constipation in patients with chronic low back pain.
Slappendel R; Simpson K; Dubois D; Keininger DL
Eur J Pain; 2006 Apr; 10(3):209-17. PubMed ID: 15914049
[TBL] [Abstract][Full Text] [Related]
2. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain.
Allan L; Richarz U; Simpson K; Slappendel R
Spine (Phila Pa 1976); 2005 Nov; 30(22):2484-90. PubMed ID: 16284584
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain.
Clark AJ; Ahmedzai SH; Allan LG; Camacho F; Horbay GL; Richarz U; Simpson K
Curr Med Res Opin; 2004 Sep; 20(9):1419-28. PubMed ID: 15383190
[TBL] [Abstract][Full Text] [Related]
4. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.
Kalso E; Simpson KH; Slappendel R; Dejonckheere J; Richarz U
BMC Med; 2007 Dec; 5():39. PubMed ID: 18154644
[TBL] [Abstract][Full Text] [Related]
5. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
6. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain.
van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW
Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516
[TBL] [Abstract][Full Text] [Related]
7. Confirmatory factor analysis of the Patient Assessment of Constipation-Symptoms (PAC-SYM) among patients with chronic constipation.
Neri L; Conway PM; Basilisco G;
Qual Life Res; 2015 Jul; 24(7):1597-605. PubMed ID: 25522976
[TBL] [Abstract][Full Text] [Related]
8. Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.
Marciniak CM; Toledo S; Lee J; Jesselson M; Bateman J; Grover B; Tierny J
World J Gastroenterol; 2014 Nov; 20(43):16323-33. PubMed ID: 25473191
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of TD-fentanyl with sustained-release morphine in the pain treatment of patients with lung cancer].
Oztürk T; Karadibak K; Catal D; Cakan A; Tugsavul F; Cirak K
Agri; 2008 Jul; 20(3):20-5. PubMed ID: 19085178
[TBL] [Abstract][Full Text] [Related]
10. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.
Radbruch L; Sabatowski R; Loick G; Kulbe C; Kasper M; Grond S; Lehmann KA
Palliat Med; 2000 Mar; 14(2):111-9. PubMed ID: 10829145
[TBL] [Abstract][Full Text] [Related]
11. Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation.
Argoff CE; Brennan MJ; Camilleri M; Davies A; Fudin J; Galluzzi KE; Gudin J; Lembo A; Stanos SP; Webster LR
Pain Med; 2015 Dec; 16(12):2324-37. PubMed ID: 26582720
[TBL] [Abstract][Full Text] [Related]
12. Psychometric validation of a constipation symptom assessment questionnaire.
Frank L; Kleinman L; Farup C; Taylor L; Miner P
Scand J Gastroenterol; 1999 Sep; 34(9):870-7. PubMed ID: 10522604
[TBL] [Abstract][Full Text] [Related]
13. Observational, nonintervention, multicenter study for validation of the Bowel Function Index for constipation in European countries.
Rentz AM; van Hanswijck de Jonge P; Leyendecker P; Hopp M
Curr Med Res Opin; 2011 Jan; 27(1):35-44. PubMed ID: 21083515
[TBL] [Abstract][Full Text] [Related]
14. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.
Allan L; Hays H; Jensen NH; de Waroux BL; Bolt M; Donald R; Kalso E
BMJ; 2001 May; 322(7295):1154-8. PubMed ID: 11348910
[TBL] [Abstract][Full Text] [Related]
15. Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation.
Tack J; Camilleri M; Hale M; Morlion B; Nalamachu S; Webster L; Wild J
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):855-863. PubMed ID: 33965574
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
17. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
18. Bowel function after tapentadol and oxycodone immediate release (IR) treatment in patients with low back or osteoarthritis pain.
Kwong WJ; Hammond G; Upmalis D; Okamoto A; Yang M; Kavanagh S
Clin J Pain; 2013 Aug; 29(8):664-72. PubMed ID: 23835764
[TBL] [Abstract][Full Text] [Related]
19. Translating Clinical Findings into the Patient's Perspective: Post-hoc Pooled Analysis of Bowel Movement Changes as a Predictor of Improvement in Patients' Opioid-induced Constipation Symptoms and Outcomes.
Coyne KS; Poon JL; Thompson C; Hu Y; Datto CJ; Sostek M
Clin Ther; 2017 Jan; 39(1):75-88. PubMed ID: 27938897
[TBL] [Abstract][Full Text] [Related]
20. Validity and reliability of the patient assessment of constipation quality of life questionnaire for the Turkish population.
Bengi G; Yalçın M; Akpınar H; Keskinoğlu P; Ellidokuz H
Turk J Gastroenterol; 2015 Jul; 26(4):309-14. PubMed ID: 26039000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
